
The rare side-effect of myocarditis from the COVID-19 mRNA vaccine is more mild in adolescents and young adults than complications from the virus itself, experts say.
A new study by researchers from Melbourne's Monash Children's Hospital (MCH), Monash Health and Monash University shows the heart condition found in adolescents aged 12 to 18 was less common and had a "mild, self-resolving clinical course".